In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 3340-78-1, name is 2-Phenyl-1,2,3,4-tetrahydroisoquinoline, introducing its new discovery. Application In Synthesis of 2-Phenyl-1,2,3,4-tetrahydroisoquinoline
A highly efficient heterogeneous ruthenium-catalysed oxidative alpha-cyanation of tertiary amines leading to alpha-aminonitriles
Oxidative alpha-cyanation of tertiary amines was achieved by using an MCM-41-immobilised N-alkylethylenediamine ruthenium(III) complex (MCM-41-2N-RuCl3) as catalyst in MeOH at 60 ºC in the presence of H2O2 as oxidant and NaCN in acetic acid as a cyanide source to afford the corresponding alpha-aminonitriles in good yields. The new heterogeneous ruthenium catalyst can easily be prepared by a simple two-step procedure from commercially readily available and inexpensive reagents. It can be recovered by filtration of the reaction solution and reused at least 7 times without significant loss of activity.
We’ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 3340-78-1, and how the biochemistry of the body works.Application In Synthesis of 2-Phenyl-1,2,3,4-tetrahydroisoquinoline
Reference：
Tetrahydroisoquinoline – Wikipedia,
1,2,3,4-Tetrahydroisoquinoline | C9H11N – PubChem